Home

The Alzheimer Society of Toronto is here to help

Welcome to the Alzheimer Society of Toronto!

IG Private Wealth Management Unforgettable Gala

Join us for the IG Private Wealth Management Unforgettable Gala on Wednesday, October 29, 2025! This special evening brings together friends, colleagues and business leaders to raise funds to meet the needs of families and individuals living with dementia. As the number of Torontonians touched by dementia continues to grow, your support will help ensure everyone who requests it can have access to the crucial programs, resources and care needed to help navigate the dementia journey.

October 29, 2025

Health Canada approves Lecanemab

Health Canada just announced that they have provided conditional approval to Lecanemab (brand name: Leqembi). This marks the first-ever disease-modifying treatment approved for use in Canada for Alzheimer’s Disease. It’s big step in the treatment of Alzheimer’s.

Here are some key things to note:

  • This is not a cure, but a treatment. Clinical trials show that lecanemab slows the progression of Alzheimer’s disease – it doesn’t stop it.
  • Even though the drug has been approved, that does not necessarily mean it will be available. Provinces and private insurers will need to decide if they will fund this treatment and who they will fund it for. Costs in the US exceed $20,000 per year. The Alzheimer Societies in Ontario have been advocating for the Province to get ready for this treatment – now is the time for them to step up
  • Only people with mild cognitive impairment or mild dementia due to Alzheimer’s disease will be eligible for treatment, a challenge when getting an early diagnosis can be difficult due to wait times or delay in recognizing the need for one.
  • Regular monitoring through a MRI is required once you’re on the treatment to watch for side effects.

The Alzheimer Society of Toronto welcomes Health Canada’s accelerated approval of Lecanemab, a landmark moment in the treatment for Alzheimer’s disease, but this announcement while a step forward, is only the beginning. This approval marks a hopeful step forward but reminds us that progress must reach everyone — through fair access, early diagnosis, quality imaging, and well-prepared healthcare teams. Everyone affected by dementia must have the chance to benefit from these advances.

Find Programs

Help ease the way through a difficult journey

Your generosity helps us provide needed support, information and education to people with dementia, their families and caregivers. 

Are you a Health Care Professional?

Learn how to make referrals to our First Link® program to ensure that individuals and families living with dementia receive the support and information they need.

Volunteer

Volunteers are an essential part of our success as an organization. With your help and contribution, we will continue to develop vibrant communities free of stigma while fostering the inclusion of people living with dementia, their families, neighbours, coworkers, and care partners.